Normal view MARC view ISBD view

Smear Layer Removal and Microhardness Alteration Potential of a Naturally Occurring Antioxidant - An In Vitro Study. [electronic resource]

By:

Rajakumaran, Arasappan

Contributor(s):

Publication details: Cureus Jul 2019Description: e5241 p. digitalISSN:

2168-8184

Online resources:

Available from publisher's website

In: Cureus vol. 11

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1381 Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality.
by Rivera-Caravaca, José Miguel
1382 Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
by Lip, Gregory Y H
1383 Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
by Lip, Gregory Y H
1384 A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials.
by Rivera-Caravaca, José Miguel
1385 Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
by Lip, Gregory Y H
1386 Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.
by Kornej, Jelena
1387 Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study.
by Wolsk, Emil
1388 Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).
by Jaakkola, Samuli
1389 Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA
by Rivera-Caravaca, José Miguel
1390 Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.
by Rivera-Caravaca, José Miguel
1391 Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries.
by Bonde, Anders Nissen
1392 Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
by Esteve-Pastor, María Asunción
1393 Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
by Pastori, Daniele
1394 Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA
by Rivera-Caravaca, José Miguel
1395 Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
by Kea, Bory
1396 Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study.
by Nielsen, Peter Brønnum
1397 Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study.
by Overvad, Thure Filskov
1398 Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
by Pineda, Javier
1399 Measurement of rivaroxaban and apixaban in serum samples of patients.
by Harenberg, Job
1400 Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation.
by Lip, Gregory Y H